PlainBillCongress, translated.Legislation. Context. Public interest.Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Congressional Research Service
Version 00 · Introduced in Senate · May 9, 2000
Drug Treatment and Research Enhancement Act - Directs the Attorney General to award a grant to the Parents Collaboration to conduct a national campaign to help parents and families prevent drug abuse by children.Authorizes the Director of the Office of National Drug Control Policy to award a grant to establish a National Community Antidrug Coalition Institute to provide antidrug education, training, and technical assistance to coalition leaders and community teams, to conduct related research and testing, and to translate knowledge from research into practical information.Key Professionals Education Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services to award grants to help key professionals participate in antidrug coalitions to identify and help youth affected by familial substance abuse.Requires the Director of the National Institute on Drug Abuse to establish a National Drug Abuse Treatment Clinical Trials Network to conduct large-scale drug abuse treatment studies.Adolescent Therapeutic Community Treatment Programs Act - Directs the Secretary to award competitive grants to enable treatment providers who administer substance abuse treatment programs to establish adolescent residential substance abuse treatment programs for individuals between 14 and 21 years old.Requires the Director of the Federal Bureau of Prisons to establish residential drug abuse treatment units in Federal prisons.Extends through FY 2007 the drug-free communities support program.Directs the Counter-Drug Technology Assessment Center to study the number of individuals engaged in sustained heroin use.Establishes 4000 as the minimum (currently, the maximum) number of members of the National Guard that shall be on duty at year's end to perform drug interdiction or counter-drug activities.Expresses the sense of Congress that the National Institutes of Health should work with private industry to promote research regarding pharmacological options to support drug treatment efforts.Authorizes appropriations.
People & committees
Sen. Grassley, Chuck [R-IA] · R–IA
Legislative record
A procedural vote is different from passage. Passage in one chamber does not establish enactment. Explore the glossary.
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sponsor introductory remarks on measure. (CR S3735-3736)
Introduced in Senate
Primary sources
Text links open the official source. We currently store references to these documents.
No related bills are listed in this snapshot. This does not establish whether the proposal has appeared in earlier Congresses.
Source last updated: Aug 20, 2025. Consult Congress.gov for the current record.
AI Conversation Starters
Choose a perspective, copy a prompt, and paste it into your preferred AI. Each prompt includes the bill version and available official source links, and asks for counterarguments as well as supporting evidence.
Analyze S.2527 as objectively as possible. Explain its main provisions, who would be affected, possible benefits and harms, implementation, exceptions, and uncertainties. Present the strongest arguments for and against it, and identify evidence needed to assess its public impact.
Examine S.2527 through a progressive lens, focusing on fairness, access, economic inequality, and effects on vulnerable communities. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and distinguish stated goals from demonstrated outcomes.
Examine S.2527 through a conservative lens, focusing on fiscal responsibility, institutional stability, federalism, and the scope of government. Explain potential benefits, costs, and unintended consequences. Consider the strongest counterarguments and any provisions that challenge this perspective.
Examine S.2527 through a civil-liberties and limited-government lens. Consider individual rights, privacy, voluntary choice, accountability, and government power. Explain tradeoffs, possible safeguards, and the strongest counterarguments without assuming the proposal is beneficial or harmful.